Cite
Cemiplimab combined with chemotherapy chemotherapy in advanced non-small cell lung cancer: an updated EMPOWER-Lung 3 trial-based cost-effectiveness analysis
MLA
Gaofeng Zhu, et al. “Cemiplimab Combined with Chemotherapy Chemotherapy in Advanced Non-Small Cell Lung Cancer: An Updated EMPOWER-Lung 3 Trial-Based Cost-Effectiveness Analysis.” Therapeutic Advances in Medical Oncology, vol. 15, Nov. 2023. EBSCOhost, https://doi.org/10.1177/17588359231213619.
APA
Gaofeng Zhu, Hongfu Cai, & Zhiwei Zheng. (2023). Cemiplimab combined with chemotherapy chemotherapy in advanced non-small cell lung cancer: an updated EMPOWER-Lung 3 trial-based cost-effectiveness analysis. Therapeutic Advances in Medical Oncology, 15. https://doi.org/10.1177/17588359231213619
Chicago
Gaofeng Zhu, Hongfu Cai, and Zhiwei Zheng. 2023. “Cemiplimab Combined with Chemotherapy Chemotherapy in Advanced Non-Small Cell Lung Cancer: An Updated EMPOWER-Lung 3 Trial-Based Cost-Effectiveness Analysis.” Therapeutic Advances in Medical Oncology 15 (November). doi:10.1177/17588359231213619.